Declaration of Helsinki should be strengthened. Equipoise is essential principle of human experimentation.
作者信息
Lilford R J, Djulbegovic B
出版信息
BMJ. 2001 Feb 3;322(7281):299-300.
Abstract
摘要
相似文献
1
Declaration of Helsinki should be strengthened. Equipoise is essential principle of human experimentation.
BMJ. 2001 Feb 3;322(7281):299-300.
2
The need to revise the Declaration of Helsinki.
N Engl J Med. 1999 Aug 12;341(7):531-4. doi: 10.1056/NEJM199908123410713.
3
Declaration of Helsinki--nothing to declare?
Lancet. 1999 Apr 17;353(9161):1285.
4
The Declaration of Helsinki, CIOMS and the ethics of research on vulnerable populations.
Nat Med. 2000 Jun;6(6):615-7. doi: 10.1038/76174.
5
Should the Declaration of Helsinki be revised?
N Engl J Med. 1999 Dec 9;341(24):1851; author reply 1853. doi: 10.1056/NEJM199912093412414.
6
Is informed consent always necessary for randomized, controlled trials?
N Engl J Med. 1999 Mar 11;340(10):804-7. doi: 10.1056/NEJM199903113401013.
7
The revision of the Declaration of Helsinki: past, present and future.
Br J Clin Pharmacol. 2004 Jun;57(6):695-713. doi: 10.1111/j.1365-2125.2004.02103.x.
8
Fifth revision of Declaration of Helsinki. Clause 29 forbids trials from using placebos when effective treatment exists.
BMJ. 2002 Apr 20;324(7343):975.
9
Placebo-controlled trials and the Declaration of Helsinki.
Lancet. 2002 Apr 13;359(9314):1337-40. doi: 10.1016/S0140-6736(02)08277-6.
10
Declaration of Helsinki. Recommendations guiding medical doctors in biomedical research involving human subjects.
Ugeskr Laeger. 1976 Feb 9;138(7):399-400.
引用本文的文献
1
New treatments compared to established treatments in randomized trials.
Cochrane Database Syst Rev. 2012 Oct 17;10(10):MR000024. doi: 10.1002/14651858.MR000024.pub3.
2
Acknowledgment of uncertainty: a fundamental means to ensure scientific and ethical validity in clinical research.
Curr Oncol Rep. 2001 Sep;3(5):389-95. doi: 10.1007/s11912-001-0024-5.
本文引用的文献
1
International research ethics.
Bioethics. 2000 Apr;14(2):158-72. doi: 10.1111/1467-8519.00187.
2
Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.
Ann Intern Med. 2000 Sep 19;133(6):464-70. doi: 10.7326/0003-4819-133-6-200009190-00015.
3
Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.
Ann Intern Med. 2000 Sep 19;133(6):455-63. doi: 10.7326/0003-4819-133-6-200009190-00014.
4
The uncertainty principle and industry-sponsored research.
Lancet. 2000 Aug 19;356(9230):635-8. doi: 10.1016/S0140-6736(00)02605-2.
5
Declaration of Helsinki should be strengthened.
BMJ. 2000 Aug 12;321(7258):442-5.
6
Ethical issues in the design and conduct of randomised controlled trials.
Health Technol Assess. 1998 Dec;2(15):i-vi, 1-132.
7
Trials: the next 50 years. Large scale randomised evidence of moderate benefits.
BMJ. 1998 Oct 31;317(7167):1170-1. doi: 10.1136/bmj.317.7167.1170.
8
Equipoise and the ethics of randomization.
J R Soc Med. 1995 Oct;88(10):552-9.
9
The fiction of informed consent.
JAMA. 1976 Apr 12;235(15):1579-84.
Zotero 插件